Bevacizumab for the treatment of glioblastoma
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Neurology (clinical),General Neuroscience
Link
http://www.tandfonline.com/doi/pdf/10.1586/14737175.2013.827414
Reference110 articles.
1. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2. Predicting Adverse Events in Children With Fever and Chemotherapy-Induced Neutropenia: The Prospective Multicenter SPOG 2003 FN Study
3. Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma
4. Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
5. Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug Delivery to Primary and Metastatic Brain Tumors: Challenges and Opportunities;Drug Delivery to the Brain;2022
2. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy;Frontiers in Cellular Neuroscience;2021-11-17
3. Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells;Scientific Reports;2017-03-13
4. Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside;CASP J INTERN MED;2017
5. Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy;European Radiology;2016-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3